Errata

In the article “¹⁸F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies,” by Minoshima et al. (J Nucl Med. 2022; 63:2S–12S), Figures 4 and 5 were switched. Figure 4 should be Figure 5 and Figure 5 should be Figure 4; the legends are correct. We regret the error.

In the article “Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study,” by Shi et al. (J Nucl Med. 2020;61:1814–1819), the author line neglected to mention that Zhihong Shi, Li-ping Fu, Nan Zhang, and Xiaobin Zhao also contributed equally to this work. The authors regret the error.

In the article “Production and Supply of α-Particle -Emitting Radionuclides for Targeted α-Therapy,” by Radchenko et al. (J Nucl Med. 2021;62: 1495–1503), affiliation 10 is incorrect. Bayer American Samoa should be Bayer AS. We regret the error.

In the article “¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience,” by Sartor et al. (J Nucl Med. 2022;63:410–414), affiliation 9 is incorrect. The correct affiliation should be Nuclear Medicine and Radiometabolic Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy. The authors regret the error.